| 缩写名/全名 |
J IMMUNOTHER
JOURNAL OF IMMUNOTHERAPY |
||||||||||||||||||||||||||||
| ISSN号 | 1524-9557 | ||||||||||||||||||||||||||||
| 研究方向 | 医学-免疫学 | ||||||||||||||||||||||||||||
| 影响因子 | 2015:3.712, 2016:3.915, 2017:3.826, 2018:3.455, 2019:4.11, | ||||||||||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||||||
| 年文章数 | 47 | ||||||||||||||||||||||||||||
| 出版年份 | 1997 | ||||||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||||||||||
| 投稿链接 | http://www.editorialmanager.com/jit/default.aspx | ||||||||||||||||||||||||||||
| 投稿官网 | http://journals.lww.com/immunotherapy-journal/pages/default.aspx | ||||||||||||||||||||||||||||
| h-index | 89 | ||||||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1524-9557%5BISSN%5D | ||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines. Author: Liu J, Zhang S, Hu Y, Yang Z, Li J, Liu X, Deng L, Wang Y, Zhang X, Jiang T, Lu X. Journal: J Immunother. 2016 May;39(4):171-80. doi: 10.1097/CJI.0000000000000122. PubMed |
| 2. | The Distribution of Human Stem Cell-like Memory T Cell in Lung Cancer. Author: Hong H, Gu Y, Sheng SY, Lu CG, Zou JY, Wu CY. Journal: J Immunother. 2016 Jul-Aug;39(6):233-40. doi: 10.1097/CJI.0000000000000128. PubMed |
| 3. | Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling. Author: Bie N, Zhao X, Li Z, Qi G. Journal: J Immunother. 2016 Jul 13. [Epub ahead of print] PubMed |
| 4. | Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma. Author: Li JJ, Gu MF, Pan K, Liu LZ, Zhang H, Shen WX, Xia JC. Journal: J Immunother. 2012 Feb-Mar;35(2):189-95. doi: 10.1097/CJI.0b013e318241d9de. PubMed |
| 5. | Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells. Author: Lin G, Wang J, Lao X, Wang J, Li L, Li S, Zhang J, Dong Y, Chang AE, Li Q, Li S. Journal: J Immunother. 2012 May;35(4):337-43. doi: 10.1097/CJI.0b013e318255ada3. PubMed |
| 6. | Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas. Author: Chen C, Zhu YB, Shen Y, Zhu YH, Zhang XG, Huang JA. Journal: J Immunother. 2012 May;35(4):354-8. doi: 10.1097/CJI.0b013e31824212c4. PubMed |
|
|
